期刊文献+

根除幽门螺杆菌对糖尿病胃轻瘫的影响 被引量:11

Effect of helicobacter pylori eradication on gastroparesis and glycaemia control in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的 2型糖尿病患者较一般人群易感染幽门螺杆菌,而且根除率远低于后者,此次研究探索以呋喃唑酮为三联根除方案对糖尿病患者感染H.pylori初次治疗的疗效的比较,统计其中胃轻瘫患者缓解率。方法将112例经查14C呼气试验证实的H.pylori阳性的2型糖尿病胃轻瘫痪患者分为三组,其中A组及C组给予左氧氟沙星+呋喃唑酮+埃索美拉唑疗程(三联10d疗法),并且A组加用多潘立酮口服10 d,而B组只使用多潘立酮口服10 d,结束4周后行14C-尿素呼气试验(14C-UBT)检测,观察A、C组H.pylori根除率,胃排空试验检测根除前后糖尿病胃轻瘫患者排空时间变化。结果 C组幽门螺杆菌根除率达86.36%(47/52),而A组根除率为69.64%(38/56),两组有统计学差异(P<0.05)。A组成功根除幽门螺杆菌后胃轻瘫症状缓解率为78.9%(30/38),而B组胃轻瘫症状缓解率为53.6%(30/56),差异有统计学意义(P<0.05)。结论以呋喃唑酮为三联的10 d疗法具有较高的根除率,但在糖尿病患者中疗效相对较差,根除幽门螺杆菌可以明显改善糖尿病胃轻瘫症状。 Objective Type 2 diabetes melhius were more easily infected with H.pylori than the general population, and eradication rate is far lower than the latter, this study explored with furazolidone as the triple eradication program for diabetic patients infected with H. pylori treatment for the first time, statistics of gastroparesis patients with remis- sion rate. Methods All 112 patients with type 2 diabetes gastroparesis and 110 patients with common infected with H. pylori, confirmed by 14C breath test of H. pylori positive, were divided into three groups. A group(56) were given lev- ofloxacin + furazolidone + esomeprazole + domperidone(10 days), C group(52) patients were given levofloxacin + fu- razolidone + esomeprazole (10 days), B group (56) were only given domperidone (10 days). 4 weeks later,14C UBT were detected H.p ylori eradication. Gastric emptying test were obserevded the emptying timeof diabetic gastroparesis patients before and after h. pylori edradicated. Results Type 2 diabetes melltius eradication rate was 69.64% (38/56)A group,the C group eradication rate was 86.36%(47/52), statistical differences were founded in the two groups (P〈 0.05). The remission rate of gastroparesis in the successful eradication of helicobacter pylori (group A) was 78.9% (30/ 38), however, the gastroparesis symptom relief rate of group B was 53.6% (30/56)(P〈0.05). Conclusion With fura- zolidone as the triple therapy has high eradication rate in ten days, but relatively poor curative effect in type 2 diabetes melltius. The eradication of helicobacter pylori can obviously improve the symptoms of gastroparesis.
出处 《中国现代医生》 2014年第22期151-153,共3页 China Modern Doctor
基金 浙江省医药卫生科技计划项目(2012KYB200) 浙江省湖州市科技局项目(2012YSB15)
关键词 幽门螺杆菌 2型糖尿病 呋喃唑酮 Helicobacter pylori Type 2 diabetes Furazolidone
  • 相关文献

参考文献10

  • 1Dunn BE, Cohen H, Blaser MJ. Helicobacter pylori [J]. Clin Microbiol Rev, 1997,10 : 720-741. 被引量:1
  • 2Mehmet Demir, Huseyin Savas Gokturk, Nevin Akcaer Ozturk, et al. Efficacy of two different Helicobacter pylori eradication regimens in Patients with type 2 diabetes and the effect of helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: A randomized con- trolled study[J]. American Journal of the Medical Sciences, 2009, 338(6): 459-464. 被引量:1
  • 3王登映.根除幽门螺杆菌与治疗糖尿病性胃轻瘫的疗效分析[J].华西医学,2010,25(2):253-254. 被引量:7
  • 4孙士东,王淑芳,倪永泽,解洪媛,徐飞,毕英杰.根除幽门螺杆菌对糖尿病胃轻瘫的疗效观察[J].现代消化及介入诊疗,2009,14(1):24-25. 被引量:14
  • 5Polyzos SA, Kountouras J, Zavos C, et al. The associa- tion between Helicobacter pylori infection and insulin re- sistance : A systematic review[J]. Helicobacter, 2011,16 (2) :79-88. 被引量:1
  • 6Ibrahim A, Zaher T, Ghonemy TA, et al. Impact of cyto- toxin-associated gene A of Helicobacter pylori strains on microalbuminuria in type 2 diabetes[J]. Saudi J Kidney Dis Transpl, 2010,21 (4) : 694-700. 被引量:1
  • 7Su P, Li Y, Li H, et al. Antibiotic resistance of Heli- cobacter pylori isolated in the Southeast Coastal[J]. Heli- cobacter, 2013,18(4) :274-279. 被引量:1
  • 8张勇,吴杰,贾业贵.以左旋氧氟沙星为基础抗幽门螺杆菌补救治疗的疗效观察[J].临床消化病杂志,2007,19(5):320-321. 被引量:10
  • 9Guvener N, Akcan Y, Paksoy I, et al. Helicobacter py- lori associated gastric pathology in patients with type II diabetes mellitus and its relationship with gastric emptying: The Ankara study[J]. Exp Clin Endocrinol Diabetes, 1999,107(3) : 172-176. 被引量:1
  • 10Vafaeimanesh J, Rajabzadeh R, Ahmadi A,et al. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens[J]. Arab J Gastroenterol, 2013, 14(2) : 55-58. 被引量:1

二级参考文献10

共引文献25

同被引文献175

  • 1周健,贾伟平.血糖稳定性的意义及临床评估[J].中华医学杂志,2006,86(30):2154-2157. 被引量:74
  • 2刘春雷,王江滨.应重视糖尿病患者的幽门螺杆菌感染[J].国际消化病杂志,2007,27(1):35-38. 被引量:27
  • 3姜薇,马秀萍,张芬茹,党亚萍.胃排空与糖尿病胃瘫[J].陕西医学杂志,1997,26(6):366-367. 被引量:11
  • 4Park M J,Choi S H,Kim D,et al.Association between Helicobacter pylori seropositivity and the coronary artery calcium score in a screening population[J].Gut liver,2011,5(3):321-327. 被引量:1
  • 5Rasmi Y,Raeisi S,Seyyed Mohammadzad MH.Association of infla mmation and cytotoxin-associated gene a positive strains of helicobacter pylori in cardiac syndromex[J].Helicobacter,2012,17(2):116-120. 被引量:1
  • 6Manuel Mayr,Stefan Kiechl.Increased Risk of Atherosclerosis Is Confined to Cag A-Positive Helicobacter pylori Strains:Prospective results from the Bruneck stody[J].Stroke,2003,34(3):610-615. 被引量:1
  • 7Kurata Y.The future expected therapeutic approaches for ITP patients[J].Nihon Rinsho,2003,61(4):664-669. 被引量:1
  • 8Sfarti C, Trifan A, Hutanasu C, Cojocariu C, Singeap AM, Stanciu C. Prevalence of gastroparesis in type 1 diabetes mellitus and its relationship to dyspeptic symptoms. J Gastrointestin Liver Dis 2010; 19: 279-2[84. 被引量:1
  • 9Thazhath SS, Jones KL, Horowitz M, Rayner CK. Diabetic gastroparesis: recent insights into pathophysiology and implications for management. Expert Rev Gastroenterol Hepatol 2013; 7: 127-139. 被引量:1
  • 10Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12; quiz e7. 被引量:1

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部